PP_1170x120_10-25-21

ziprasidone mesylate for injection

Dr. Reddy’s introduces ziprasidone mesylate for injection

Dr. Reddy’s introduces ziprasidone mesylate for injection

PRINCETON, N.J. — Dr. Reddy’s  has launched ziprasidone mesylate for injection, 20 mg (base)/mL single-dose vials, the therapeutic generic equivalent of Geodon (ziprasidone mesylate) Injection, 20 mg/mL, approved by the U.S. Food and Drug Administration. “We’re pleased to bring the first generic of ziprasidone mesylate for injection to market for patients who will benefit from

Adheris Health